---
document_datetime: 2025-12-16 12:56:58
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/seffalair-spiromax-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: seffalair-spiromax-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.9289805
conversion_datetime: 2025-12-20 18:07:15.220876
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Seffalair Spiromax

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Renewal - 5 year /   | - Renewal - | 16/10/2025                          | 12/12/2025                                  | SmPC,                            |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                       | Renewal of marketing authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |            | Labelling and PL   | EMA/R/0000280812   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------------|--------------------|
| Variation type IB / EMA/VR/0000267107 | B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.z Other changes - Accepted                                                                                                                                                                                                                                                                                                                   | 21/05/2025 | N/A        |                    |                    |
| Variation type IA / EMA/VR/0000258407 | B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.a Minor change in the manufacturing process - Refused                                                                                                                                                                                                                                                                                        | 10/04/2025 | N/A        |                    |                    |
| Article 61(3) /                       | - Notification acc. Article 61(3) - Accepted Update of the package leaflet with revised details of local representatives and to delete United Kingdom (Northern Ireland) from the list of local representatives in line with QRD template v10.4. Additionally, the MAH removed the grey-shading for the manufacturer in section '6. Contents of the pack and other information' and took the opportunity to introduce a minor editorial amendment to the Lithuanian translation of the package leaflet. | 03/04/2025 | 12/12/2025 | PL                 | EMA/N/0000258664   |
| Variation type IA / EMA/VR/0000253346 | B.III.1.a European Pharmacopoeial Certificate of Suitability to the relevant Ph.                                                                                                                                                                                                                                                                                                                                                                                                                        | 25/03/2025 | N/A        |                    |                    |

<div style=\"page-break-after: always\"></div>

|                                       | Eur. Monograph - B.III.1.a.2 Updated certificate from an already approved manufacturer - Accepted                                                             |            |             |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-------------|
| Variation type IA / EMA/VR/0000245601 | B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted | 28/01/2025 |             |
| PSUR / EMA/PSUR/0000268979            | - -                                                                                                                                                           |            | Maintenance |